Cargando…
HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
OBJECTIVE: To study the influence of glycosylated haemoglobin (HbA1c) on response of bevacizumab in patients with diabetic macular oedema. METHODS AND ANALYSIS: A total of 37 eyes of 37 patients with vision loss due to diabetic macular oedema treated with bevacizumab were included in this study. Par...
Autores principales: | Sharma, Sadhana, Joshi, Sagun Narayan, Karki, Pratap |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228525/ https://www.ncbi.nlm.nih.gov/pubmed/32426522 http://dx.doi.org/10.1136/bmjophth-2020-000449 |
Ejemplares similares
-
Evaluation of effect of bevacizumab on central subfield macular thickness in the injected and contralateral (untreated) eye of patients with bilateral diabetic macular oedema
por: Khatri, Anadi, et al.
Publicado: (2017) -
Optical coherence tomography patterns of diabetic macular edema and
treatment response to bevacizumab: a short-term study
por: Sharma, Sadhana, et al.
Publicado: (2022) -
Influence of glycaemic control on macular thickness in diabetic retinopathy
por: Sharma, Sadhana, et al.
Publicado: (2021) -
Purtscher-like retinopathy with serous macular detachment in a case of acute pancreatitis: A case report
por: Sharma, Sadhana, et al.
Publicado: (2023) -
Outcome of intravitreal bevacizumab injection without pre and postoperative antibiotics
por: Shrestha, Ruchi, et al.
Publicado: (2020)